Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-25-013287
Filing Date
2025-01-27
Accepted
2025-01-27 16:05:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d855976d8a12b.htm 8-A12B 13361
  Complete submission text file 0001193125-25-013287.txt   14412
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-42490 | Film No.: 25559030
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)